Expanding the substantial interactome of NEMO using protein microarrays

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Fenner, Beau J ^a   Scannell, Michael ^a   Prehn, Jochen H M ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALBINDIN 1; CYCLIN DEPENDENT KINASE 2; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; SAG PROTEIN; SUMO 2 PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; I KAPPA B KINASE; IKBKG PROTEIN, HUMAN; PRIMER DNA; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; IMMUNOPRECIPITATION; KIDNEY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; CELL LINE; METABOLISM; POLYMERASE CHAIN REACTION; PROTEIN BINDING; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 77649314475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008799     Document Type: Article

References (50)

1. Skaug B, Jiang X, Chen ZJ (2009) The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78: 769-796.
2. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
3. Mankan AK, Lawless MW, Gray SG, Kelleher D, McManus R (2009) NF-kappaB regulation: the nuclear response. J Cell Mol Med 13: 631-643.
4. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
5. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, et al. (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93: 1231-1240.
6. Poyet JL, Srinivasula SM, Lin JH, Fernandes-Alnemri T, Yamaoka S, et al. (2000) Activation of the Ikappa B kinases by RIP via IKKgamma/NEMO-mediated oligomerization. J Biol Chem 275: 37966-37977.
7. Cooke EL, Uings IJ, Xia CL, Woo P, Ray KP (2001) Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. Biochem J 359: 403-410.
8. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22: 245-257.
9. Li H, Kobayashi M, Blonska M, You Y, Lin X (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 281: 13636-13643.
10. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat Cell Biol 8: 398-406.
11. Cordier F, Grubisha O, Traincard F, Veron M, Delepierre M, et al. (2009) The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem 284: 2902-2907.
12. Fenner BJ, Scannell M, Prehn JH (2009) Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays. Biochim Biophys Acta E-pub ahead of print.
13. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S (2006) Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311: 1141-1146.
14. Mabb AM, Wuerzberger-Davis SM, Miyamoto S (2006) PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol 8: 986-993.
15. Wu ZH, Miyamoto S (2008) Induction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stress. EMBO J 27: 1963-1973.
16. Sebban H, Yamaoka S, Courtois G (2006) Posttranslational modifications of NEMO and its partners in NF-kappaB signaling. Trends Cell Biol 16: 569-577.
17. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, et al. (2004) A physical and functional map of the human TNF-alpha/NF-kappaB signal transduction pathway. Nat Cell Biol 6: 97-105.
18. Chariot A, Leonardi A, Muller J, Bonif M, Brown K, et al. (2002) Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 277: 37029-37036.
19. Higashimoto T, Chan N, Lee YK, Zandi E (2008) Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1. J Biol Chem 283: 35354-35367.
20. Kim YS, Lee JY, Son MY, Park W, Bae YS (2003) Phosphorylation of threonine 10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase CKII promotes the degradation of IkappaBalpha and p27Kip1. J Biol Chem 278: 28462-28469.
21. Tian Y, Zhang Y, Zhong B, Wang YY, Diao FC, et al. (2007) RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation. J Biol Chem 282: 16776-16782.
22. Carr CM, Munson M (2007) Tag team action at the synapse. EMBO Rep 8: 834-838.
23. Wang HJ, Cao JP, Yu JK, Zhang LC, Jiang ZJ, et al. (2008) Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway. Eur J Pharmacol 595: 7-12.
24. Chen E, Li CC (1998) Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase. Biochem Biophys Res Commun 249: 728-734.
25. Gu Q, Bowden GT, Normolle D, Sun Y (2007) SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/ NF-kappaB. J Cell Biol 178: 1009-1023.
26. Mabb AM, Miyamoto S (2007) SUMO and NF-kappaB ties. Cell Mol Life Sci 64: 1979-1996.
27. Yoshihara M, Montana ES (2004) The synaptotagmins: calcium sensors for vesicular trafficking. Neuroscientist 10: 566-574.
28. Koh TW, Bellen HJ (2003) Synaptotagmin I, a Ca2+ sensor for neurotransmitter release. Trends Neurosci 26: 413-422.
29. Rizo J, Rosenmund C (2008) Synaptic vesicle fusion. Nat Struct Mol Biol 15: 665-674.
30. Levy ED, Landry CR, Michnick SW (2009) How perfect can protein interactomes be? Sci Signal 2: pe11.
31. Satoh J, Nanri Y, Yamamura T (2006) Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods 152: 278-288.
32. Tong Y, Ben-Shlomo A, Zhou C, Wawrowsky K, Melmed S (2008) Pituitary tumor transforming gene 1 regulates Aurora kinase A activity. Oncogene 27: 6385-6395.
33. Satoh J, Obayashi S, Misawa T, Sumiyoshi K, Oosumi K, et al. (2009) Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 35: 16-35.
34. 2+ buffers. Cell Mol Life Sci 66: 275-300.
35. Kojetin DJ, Venters RA, Kordys DR, Thompson RJ, Kumar R, et al. (2006) Structure, binding interface and hydrophobic transitions of Ca2+-loaded calbindin-D(28K). Nat Struct Mol Biol 13: 641-647.
36. Berchtold CM, Wu ZH, Huang TT, Miyamoto S (2007) Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli. Mol Cell Biol 27: 497-509.
37. Madziva MT, Bai J, Bhalla A, Chapman ER, Edwardson JM (2005) Effects of synaptotagmin reveal two distinct mechanisms of agonist-stimulated internalization of the M4 muscarinic acetylcholine receptor. Br J Pharmacol 144: 761-771.
38. Tan M, Gallegos JR, Gu Q, Huang Y, Li J, et al. (2006) SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia 8: 1042-1054.
39. Yang GY, Pang L, Ge HL, Tan M, Ye W, et al. (2001) Attenuation of ischemiainduced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab 21: 722-733.
40. Tan M, Gu Q, He H, Pamarthy D, Semenza GL, et al. (2008) SAG/ROC2/ RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. Oncogene 27: 1404-1411.
41. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576.
42. Wuerzberger-Davis SM, Nakamura Y, Seufzer BJ, Miyamoto S (2007) NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene 26: 641-651.
43. Hay RT (2004) Modifying NEMO. Nat Cell Biol 6: 89-91.
44. Zhang H, Saitoh H, Matunis MJ (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol 22: 6498-6508.
45. Mukhopadhyay D, Dasso M (2007) Modification in reverse: the SUMO proteases. Trends Biochem Sci 32: 286-295.
46. Au SW, Lam KH, Lam WL, Lam LS, Chan HY, et al. (2009) SUMO proteases: Redox regulation and biological consequences. Antioxid Redox Signal.
47. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866.
48. van den Heuvel S, Harlow E (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
49. Cheng J, Wang D, Wang Z, Yeh ET (2004) SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 24: 6021-6028.
50. Moon KY, Hahn BS, Lee J, Kim YS (2001) A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal Biochem 292: 17-21.